Xagrid - direct healthcare professional communication (DHPC)

anagrelide
DHPCHuman

Greek is available via eTranslation, the European Commission's machine translation service.

Translate to Greek | Important information about machine translation

Περί

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Έγγραφα

Direct healthcare professional communication (DHPC): Xagrid (anagrelide hydrochloride): Risk of thrombosis including cerebral infarction upon abrupt treatment discontinuation

English (EN) (127.67 KB - PDF)

Δημοσιεύθηκε για πρώτη φορά:
Προβολή

Key facts

Medicine name
Xagrid
Active substance
anagrelide
Therapeutic area (MeSH)
Thrombocythemia, Essential
Procedure number
EMEA/H/C/000480/II/091
Regulatory outcome
Variation
DHPC type
Safety signal
Human ATC codes
L01XX35
Dissemination date

Share this page